|
||||||||
 |
||||||||
What Results Have
Others Reported? In 1997, Grace Halloran presented
the results of a two year study done in conjunction with the neuro-ophthalmogist
August L. Reader,M.D.,F.A.C.S. at the Proceedings of the Fourth
International Symposium On Biologically Closed Electric Circuits.
Thirty patients were treated who had a variety of retinal diseases.
Their therapy protocol consisted mainly of microcurrent stimulation
therapy. 80% of the people in this study with macular degeneration
showed improvements in one or both eyes as measured by visual acuity
testing and visual field testing. The results in those patients
with retinitis pigmentosa were equally remarkable. The results of
this two year study were also published in the Townsend Letter
for Doctors and Patients, April, 1998. In an article on Grace
Halloran in the health magazine Let's Live, March, 1998,
Grace reports that in her first series of patients treated between
1983 and 1985, 98 out of 114 participants in her program had improvements
in their vision. At this same conference in
1997, John Jarding, O.D. presented the results of work with a group
of patients with macular degeneration begun by Leland Michael, O.D.(deceased)
and continued by Jarding. By the time of this presentation, John
Jarding was using the microcurrent stimulator from MicroStim, Inc.
that is used in this office. He reported that over 50% of the patients
in the study showed improvements in vision. More significantly,
some of the patients in this series had been treated since 1985,
and the long term follow-up had showed that as long as the treatments
were continued, the improvements persisted. Even in those patients
who had little improvement, in almost all the patients, the progression
of their macular degeneration had significantly slowed or stopped. Ophthalmologists in Florida,
Hawaii and Pennsylvania have recently begun treating patients with
microcurrent stimulation therapy. In private correspondence, they
report that well over half of the people they have treated have
had statistically significant improvements in their vision. Public
presentation of their results is awaited. Please see the section on Results From the First 121 Patients Treated. to see how the people we have seen in this office are doing. Of all 121 patients treated, 83% (101/121) showed improvement of greater than or equal to two lines of visual acuity in one or both eyes. If we include those who had at least one line of improvement in visual acuity, then 93% showed improvement. Return to Macular Degeneration Home Page
|
||||||||
